Drug Shortage Report for SANDOZ SAXAGLIPTIN

Last updated on 2022-06-23 History
Report ID 161201
Drug Identification Number 02468611
Brand name SANDOZ SAXAGLIPTIN
Common or Proper name SAXAGLIPTIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SAXAGLIPTIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30FCT
ATC code A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-24
Estimated end date 2022-06-17
Actual end date 2022-06-22
Shortage status Resolved
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-05-24 English Compare
v2 2022-05-24 French Compare
v3 2022-06-22 English Compare
v4 2022-06-22 French Compare
v5 2022-06-23 English Compare

Showing 1 to 5 of 5